Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 347

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer

Open access
Guan, Yinghui, Kuo, Wen-Lin, Stilwell, Jackie L., Takano, Hirokuni, Lapuk, Anna V., Fridlyand, Jane, Mao, Jian-Hua, Yu, Mamie, Miller, Melinda A., Santos, Jennifer L., Kalloger, Steve E., Carlson, Joseph W., Ginzinger, David G., Celniker, Susan E., Mills, Gordon B., Huntsman, David G., Gray, Joe W.·2007·Clinical Cancer Research

Abstract

Purpose: This study was designed to elucidate the role of amplification at 8q24 in the pathophysiology of ovarian and breast cancer because increased copy number at this locus is one of the most frequent genomic abnormalities in these cancers. Experimental Design: To accomplish this, we assessed the association of amplification at 8q24 with outcome in ovarian cancers using fluorescence in situ hybridization to tissue microarrays and measured responses of ovarian and breast cancer cell lines to specific small interfering RNAs against the oncogene MYC and a putative noncoding RNA, PVT1, both of which map to 8q24. Results: Amplification of 8q24 was associated with significantly reduced survival duration. In addition, small interfering RNA–mediated reduction in either PVT1 or MYC expression inhibited proliferation in breast and ovarian cancer cell lines in which they were both amplified and overexpressed but not in lines in which they were not amplified/overexpressed. Inhibition of PVT1 expression also induced a strong apoptotic response in cell lines in which it was overexpressed but not in lines in which it was not amplified/overexpressed. Inhibition of MYC, on the other hand, did not induce an apoptotic response in cell lines in which MYC was amplified and overexpressed. Conclusions: These results suggest that MYC and PVT1 contribute independently to ovarian and breast pathogenesis when overexpressed because of genomic abnormalities. They also suggest that PVT1-mediated inhibition of apoptosis may explain why amplification of 8q24 is associated with reduced survival duration in patients treated with agents that act through apoptotic mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-06-2882

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 347

Metadata

Authors
Guan, Y., Kuo, W.-L., Stilwell, J. L., Takano, H., Lapuk, A. V., Fridlyand, J., Mao, J.-H., Yu, M., Miller, M. A., Santos, J. L., Kalloger, S. E., Carlson, J. W., Ginzinger, D. G., Celniker, S. E., Mills, G. B., Huntsman, D. G., & Gray, J. W.
Venue
Clinical Cancer Research
Published
2007-10-01
Volume
13
Issue
19
Pages
5745-5755
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2088325873
Cited by
347
References
31
FWCI
2.25
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-06-2882
The paper
Guan, Y., Kuo, W.-L., Stilwell, J. L., Takano, H., Lapuk, A. V., Fridlyand, J., Mao, J.-H., Yu, M., Miller, M. A., Santos, J. L., Kalloger, S. E., Carlson, J. W., Ginzinger, D. G., Celniker, S. E., Mills, G. B., Huntsman, D. G., & Gray, J. W. (2007). Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-06-2882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.